SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-000422
Filing Date
2023-01-23
Accepted
2023-01-23 16:36:56
Documents
13
Period of Report
2023-01-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K hrmy-20230117x8k.htm   iXBRL 8-K 40323
2 GRAPHIC hrmy-20230117x8k001.jpg GRAPHIC 1167
  Complete submission text file 0001558370-23-000422.txt   163055

Data Files

Seq Description Document Type Size
3 EX-101.SCH hrmy-20230117.xsd EX-101.SCH 3162
4 EX-101.LAB hrmy-20230117_lab.xml EX-101.LAB 15927
5 EX-101.PRE hrmy-20230117_pre.xml EX-101.PRE 10080
7 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20230117x8k_htm.xml XML 4879
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39450 | Film No.: 23544898
SIC: 2834 Pharmaceutical Preparations